Permanent supportive housing overdose prevention study
Part of Mental health clinical trials.
This study tests a program to help supportive housing agencies prevent overdoses among their tenants. It is designed for agencies in New York and New Jersey that have had a recent overdose and serve at least 40 tenants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The agency must be a supportive housing agency located in New York or New Jersey.
- The agency must have had at least one tenant overdose in the past year.
- The agency must serve at least 40 tenants.
- The agency must be willing to take part in all study activities.
- Tenants participating must be 18 years or older and live in an enrolled supportive housing agency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how overdose prevention centers and syringe service programs can help people who use drugs. If you are 18 or older, have used these services in New York City recently, and have used certain drugs in the past month, you may be able to join.
This study looks at a program called the Shelter Harm Reduction Program (HRSP) in New York City shelters. It aims to see if the program helps people who use drugs and stay in shelters. Researchers will interview people who have stayed in these shelters to learn about their experiences.
This study looks at using social connections to help people who inject drugs get HIV prevention and substance use support. The trial tests a program in Los Angeles that works with friends or peers to encourage PrEP (HIV prevention pills) and addiction treatment.
This study looks at ways to improve HIV prevention and treatment for people on probation who have injected opioids. Researchers want to learn from your experiences to help create better services.
This project studies how to improve offering and completing HIV (and hepatitis C) tests in opioid treatment programs. It may help increase timely follow-up and linkage to care when results are positive.
This trial offers harm-reduction services for adults who have been misusing opioids (and sometimes other substances) recently. It’s designed to test support approaches that may reduce risks and improve well-being.
Hear when a new Overdose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.